Martin Ugander1, Abiola J. Oki1,
Peter Kellman1, Andreas Greiser2, Anthony H. Aletras1,
Andrew E. Arai1
1National Heart, Lung and Blood
Institute, National Institutes of Health, Bethesda, MD, United States; 2Siemens
AG Healthcare Sector, Erlangen, Germany
T1-mapping
of the heart before and after intravenous contrast administration can be used
to generate quantitative pixel-maps of the extracellular volume (ECV)
fraction of the myocardium in patients. The study presents comprehensive
phantom, experimental and patient validation of the T1 mapping sequence
(MOLLI) which is used to calculate ECV. The method provides images for
quantitative assessment of the ECV of the myocardium, and in principle any
other tissue, in a pixel map with a quantitative color scale ranging from
0-100%.